Showing results (1941-1950 of 2,996) with videos related to
Sort By:
Pageof 300
BJU International|April 25, 2024
First-line immunotherapy of metastatic renal cell carcinoma: an updated network meta-analysis including triplet therapyTakafumi Yanagisawa, Tatsushi Kawada, Kensuke Bekku, et al.World Journal of Urology|October 14, 2018
Regional differences in total hospital charges between open and robotically assisted radical prostatectomy in the United StatesFelix Preisser, Sebastiano Nazzani, Elio Mazzone, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2018
Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancerBernhard Grubmüller, Daniela Senn, Gero Kramer, et al.European Urology|March 14, 2007
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomyAlberto Briganti, Felix K-H Chun, Georg C Hutterer, et al.Urologic Oncology|June 25, 2020
The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohortFlorian Janisch, Tobias Hillemacher, Constantin Fuehner, et al.Cancer Epidemiology|August 7, 2021
Regional differences in patient age and prostate cancer characteristics and rates of treatment modalities in favorable and unfavorable intermediate risk prostate cancer across United States SEER registriesMike Wenzel, Claudia Collà Ruvolo, Luigi Nocera, et al.Urology|June 9, 2009
Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumorsUmberto Capitanio, Claudio Jeldres, Paul Perrotte, et al.Urology|July 25, 2009
Does histologic subtype affect oncologic outcomes after nephron-sparing surgery?Maxime Crépel, Hendrik Isbarn, Umberto Capitanio, et al.European Journal of Cancer (Oxford, England : 1990)|November 13, 2007
Prostate volume and adverse prostate cancer features: fact not artifactAlberto Briganti, Felix K-H Chun, Nazareno Suardi, et al.Urologic Oncology|August 11, 2020
Primary Ta high grade bladder tumors: Determination of the risk of progressionFahad Quhal, David D'Andrea, Francesco Soria, et al.Pageof 300